The Wolverine Stack: BPC-157 + TB-500 Recovery Protocol
- by Michael Heckert
-

The Wolverine Stack: How BPC-157 + TB-500 Got Me Back in the Ring 8 Weeks After Breaking My Hands and Destroying My Face
Disclaimer: This article is for educational and informational purposes only. BPC-157 and TB-500 are not FDA-approved for human use. All peptides referenced are sold for research purposes only and are not intended for human consumption. This reflects one individual's personal experience and does not constitute medical advice. Always consult a licensed healthcare professional before beginning any peptide protocol.
⚡ Key Takeaways (TL;DR)
- The Wolverine Stack = BPC-157 + TB-500 for maximum injury recovery speed
- BPC-157 builds blood vessels to the injury; TB-500 sends repair cells through them
- Typical timeline: 4-6 weeks acute phase, then maintenance
- Never mix in same vial — separate injection sites
- Real result: broken hand + orbital trauma back to training in 21 days

I fight bareknuckle. No gloves, no padding — just skin on bone. After my last fight, I walked away with broken hands, a severely lacerated face, bilateral orbital bruising, and wounds that needed stitching under both eyes.
Standard recovery timeline for injuries like that? Doctors said 6-8 weeks minimum before training, 12+ weeks before competing again.
I was back training in 21 days and back in the ring in 8 weeks.
This is what I ran, why it works, and how to use it yourself.
The Injury: What We're Actually Working

Bareknuckle fighting produces a specific injury profile. The damage isn't just skin-deep:
Facial lacerations — deep cuts through skin and subcutaneous tissue, high blood supply, high contamination risk
Orbital trauma — blunt impact causing suborbital bleeding, tissue swelling, potential fracture risk
Hand fractures — metacarpal stress fractures and contusions; no glove padding means bone takes the full load
Systemic inflammation — the whole body enters a trauma response; cortisol spikes, tissue breaks down, recovery is bottlenecked by inflammatory

Conventional recovery means rest, ice, NSAIDs, and time. That's the baseline. I used the baseline — and layered BPC-157 and TB-500 on top of it.
What BPC-157 and TB-500 Are (And Why They Work Together)
BPC-157: The Local Repair Signal
BPC-157 is a naturally occurring gastric peptide that promotes mucosal integrity and homeostasis. Research suggests it enhances growth hormone receptor expression and several pathways involved in cell growth and angiogenesis, while reducing inflammatory cytokines.
In plain terms: it signals the body to build new blood vessels at injury sites, accelerates collagen organization, and tells the immune response to shift from destruction to repair. In preclinical models, BPC-157 improved functional, structural, and biomechanical outcomes in muscle, tendon, ligament, and bony injuries.
TB-500: The Systemic Mobilizer
TB-500 is a synthetic analogue of thymosin beta-4, a naturally occurring 43-amino acid polypeptide found in elevated concentrations in platelets, macrophages, and wound healing tissues. Its primary molecular mechanism involves regulation of actin dynamics, facilitating cellular migration and morphological changes essential for wound healing and tissue repair.
Where BPC-157 operates locally, TB-500 is systemic. It recruits repair cells and mobilizes them to injury sites across the body. For multiple simultaneous injury sites — face, hands, soft tissue — that systemic reach matters.
Why Stack Them: The Wolverine Protocol
The Wolverine Protocol pairs BPC-157's angiogenic and growth factor modulation properties with TB-500's cell migration and anti-fibrotic effects — which may produce synergistic tissue repair outcomes.
BPC-157 builds the road. TB-500 sends the trucks. One without the other leaves half the job undone.
IMPORTANT: BPC-157 and TB-500 should never be combined into a single vial — dosing them separately preserves their stability and maximizes their therapeutic potential.
Research both compounds here: shop.bluefitmd.com/peptides?am_id=Heck
The Research on Facial and Bone Healing
On Wounds and Tissue Repair
Studies utilizing rat models of Achilles tendon injury have shown improved biomechanical properties, enhanced collagen organization, and accelerated healing kinetics following BPC-157 administration. BPC-157 demonstrates potent angiogenic properties through multiple mechanisms, including stimulation of endothelial cell migration, proliferation, and tube formation.
Enhanced collagen organization is particularly relevant for facial lacerations — proper collagen deposition is the difference between clean healing and excessive scarring.
On Bone Repair
Thymosin Beta-4 research has demonstrated effects on osteoblast differentiation and activity, suggesting a role in the mineralization phase of bone repair. Combined with BPC-157's angiogenic effects driving blood supply to fracture sites, the stack creates conditions that accelerate both phases of bone healing.
The Protocol I Used
This is what I personally ran. This is a documented personal account — not a prescription or recommendation. Starting point: Day 1 post-fight, after wound care and initial medical assessment. Duration: 6 weeks total.
For the hands, I injected BPC-157 as close to the affected metacarpals as practical via SubQ. For the face, I injected at the abdominal SubQ site and let systemic distribution handle it — injecting directly near active wound sites is not advisable.
Key protocol notes:
Start at the lower end of your dose range for 1-2 weeks and increase gradually if tolerated
Keep BPC-157 and TB-500 in separate vials — never mix them
Inject on a consistent daily schedule. Missed doses interrupt the signaling cascade
Refrigerate vials. New needle every injection. Sterility is non-negotiable
Timeline: What I Noticed
Days 1-5: Inflammation suppression was noticeable faster than expected. Bruising fully developed and peaked earlier, then started receding. Laceration sites appeared to close faster than previous post-fight experiences.
Days 5-14: Orbital bruising resolving. Hand pain still present but functional movement returning. Normally I'd still be completely off training at this point.
Day 21: Back in the gym. Light technical work, no contact — but moving and training.
Week 8: Back in the Win Column!

Honest Caveats: What the Research Actually Says
I'm a fighter and a trainer, not a doctor. The science has to be represented accurately. Despite the robust preclinical data, human clinical trials remain scarce. A systematic review published in HSS Journal in 2025 identified only one clinical study that retrospectively assessed intra-articular injection of BPC-157 for knee pain. The most recent safety pilot involved two healthy adults who received intravenous BPC-157 infusions — the treatment was well tolerated with no adverse events and plasma concentrations returned to baseline within 24 hours.
My experience is one data point. It's meaningful to me. But I'm not telling you it's proven medicine.
Important: BPC-157 is banned by the World Anti-Doping Agency (WADA) for athletes subject to testing. Know your organization's rules before running any peptide protocol.
Sourcing: What to Look For
Purity is everything. What you need from any vendor:
Published HPLC Certificate of Analysis
Mass spectrometry verification
Transparent manufacturing information
Established reputation with verifiable reviews
Clear research-purposes-only designation
For research-grade BPC-157 and TB-500 from a verified vendor with published COAs: shop.bluefitmd.com/peptides?am_id=Heck
Bottom Line
Significant damage. Broken hands. Lacerated face. Bilateral orbital trauma. Standard timeline: 12 weeks minimum to competition.
I ran BPC-157 at 500mcg daily and TB-500 at 2mg twice weekly for 6 weeks starting day one post-fight. Training at day 21. Competing at week 8.
The Wolverine stack didn't make me invincible. It didn't remove the work or the pain. What it did — in my experience — was compress the timeline and give my body the raw materials to repair faster than it would have on its own. In a sport where time off the card costs momentum, money, and ranking — that matters.
Sources: PMC/NIH — Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025); GlobalRPH — BPC-157 and TB-500: Background, Indications, Efficacy, and Safety (2025); Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing, PMC (2025); Goldstein et al., Annals of New York Academy of Sciences.
This content is for educational purposes only and does not constitute medical advice. All peptides referenced are sold for research purposes only.
| Compound | Dose | Frequency | Administration |
|---|---|---|---|
| BPC-157 | 500mcg | Once daily | SubQ injection near injury sites |
| TB-500 | 2mg | 2x per week | SubQ injection, abdominal |
Frequently Asked Questions
What is the Wolverine Stack?
How long does the Wolverine Stack take to work?
Can BPC-157 and TB-500 be mixed together?
Is the Wolverine Stack safe?
What injuries does the Wolverine Stack work for?
Where to Source Research Peptides
All peptides discussed in this article are available for research purposes through verified suppliers. King Killers recommends BlueFitMD for lab-tested, pharmaceutical-grade compounds with third-party COAs.
Code KILLA saves 15% on all King Killers apparel at checkout.
About the Author
Michael Heckert is a professional bareknuckle fighter, former powerlifter, and founder of King Killers. With over 15 years in combat sports and a background in exercise physiology, Heck has personally tested every peptide protocol documented on this site — including the Wolverine Stack that got him back in the ring after a broken hand and orbital fracture in just 21 days.
All content is based on published research and firsthand experience. Nothing on this site constitutes medical advice. Consult a licensed healthcare provider before use.
Related Reading
- BPC-157 Deep Dive: Mechanisms, Benefits & Dosing
- TB-500 Deep Dive: Systemic Healing & Recovery
- KingKillers Peptide Stacking Guide: Full Protocol
Disclaimer: This article is for educational purposes only. Peptides referenced are for research use. Consult a licensed healthcare provider before use.